(Press-News.org) In a new study, researchers at the Swedish medical university Karolinska Institutet have identified epigenetic changes – known as DNA methylation – in the blood of patients with schizophrenia. The researchers were also able to detect differences depending on how old the patients were when they developed the disease and whether they had been treated with various drugs. In the future this new knowledge may be used to develop a simple test to diagnose patients with schizophrenia.
Schizophrenia is one of our most common chronic psychiatric diseases and affects 1% of the population. It is already known that the risk of developing schizophrenia increases if one has close family members who have had the disease. At the same time, studies on identical twins, who therefore have the same genetic make-up, show that 50% of the disease risk can be explained by genetic factors. This in turn suggests that environmental factors, which include epigenetic changes to the genome, account for the remaining 50% of the cause of the disease.
"Epigenetics involves small reversible chemical changes, for instance in the form of methyl groups that bind to certain DNA sequences in the genome, that can consequently modifythe function of the DNA. The research results we are now presenting suggest that epigenetic mechanisms are of great importance in mental illness. It is particularly interesting that these changes can also be linked to age at disease onset," says Professor Tomas Ekström, who has directed the study at the Center for Molecular Medicine (CMM).
The current study, which is published in the scientific journal FASEB Journal, shows that the methylation levels in DNA in the white blood cells from individuals who suffer from schizophrenia are substantially lower than normal and that the degree of methylation is related to age of disease onset and the severity of the disease. The researchers also compared the degree of methylation in samples from patients who had been treated with various types of drugs. It emerged that treatment with one type of antipsychotic drug could influence the levels of DNA methylation in the blood cells towards more normal levels. In their article in FASEB Journal, the researchers at CMM note that at present there is no 'biomarker' for schizophrenia that is suitable for clinical sampling. An interesting area of application for the new knowledge may therefore be to develop a simple test of this kind to diagnose schizophrenia, and to monitor how patients respond to the treatment they receive.
"The fact that DNA methylation in an ordinary blood sample can be used as a marker of the severity of schizophrenia opens up completely new opportunities. But follow-up studies are needed to clarify, for example, whether choice of treatment can be linked to this type of test," says Professor Martin Schalling, one of the researchers behind the study.
###Publication: "Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset ", Philippe A. Melas, Maria Rogdaki, Urban Ösby, Martin Schalling, Catharina Lavebratt & Tomas J. Ekström, FASEB Journal, published ahead of print 16 March 2012, doi:10.1096/fj.11-202069
Read the article: http://www.fasebj.org/content/early/2012/03/16/fj.11-202069.full.pdf+html
More about CMM: http://www.cmm.ki.se/en
For further information, please contact:
Tomas Ekström, Professor
Tel: 46-517-746-34 or 46-739-82-36-11
E-mail: Tomas.ekstrom@ki.se
Martin Schalling, Professor
Tel: 46-8-517-744-81 or 46-704-84-12-30
E-mail: Martin.schalling@ki.se
Catharina Lavebratt, Associate Professor
Tel: 46-8-517-765-24
E-mail: Catharina.Lavebratt@ki.se
Contact the KI press office on: http://ki.se/pressroom
Karolinska Institutet is one of the world's leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country's broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Epigenetic changes in blood samples may point to schizophrenia
2012-03-27
ELSE PRESS RELEASES FROM THIS DATE:
IOF and ECTS issue guidance on management of glucocorticoid-induced osteoporosis
2012-03-27
Oral glucocorticoids are commonly prescribed for a wide variety of disorders, most commonly for rheumatoid arthritis, obstructive pulmonary disease and inflammatory bowel diseases. However, the use of these medications can result in rapid bone loss during the first three to six months of therapy, leading to increased risk of fragility fractures.
Although awareness of glucocorticoid-induced osteoporosis (GIO) has grown in recent years, it still remains vastly under-diagnosed and under-treated. As a result, and despite the availability of effective treatment options to ...
Taking oral glucocorticoids for 3 months or longer? Beware of osteoporosis!
2012-03-27
Millions of people around the world are prescribed glucocorticoids for a wide variety of inflammatory conditions, including, rheumatoid arthritis, asthma and inflammatory bowel diseases. Although they are effective and widely used, one of the potentially serious side effects of these medications is glucocorticoid-induced osteoporosis.
Osteoporosis is a serious condition in which bones become thinner and more fragile, making them more likely to break (fracture). Glucocorticoids can cause rapid bone loss in the first three to six months of treatment, leading to an increased ...
Engineers set their sights on asteroid deflection
2012-03-27
Pioneering engineers at the University of Strathclyde in Glasgow are developing an innovative technique based on lasers that could radically change asteroid deflection technology.
The research has unearthed the possibility of using a swarm of relatively small satellites flying in formation and cooperatively firing solar-powered lasers onto an asteroid – this would overcome the difficulties associated with current methods that are focused on large unwieldy spacecraft.
Dr Massimiliano Vasile, of Strathclyde's Department of Mechanical and Aerospace Engineering, is leading ...
Solution does not reduce rate of progression to development of heart attack after chest pain
2012-03-27
Patients experiencing symptoms such as chest pain who received from paramedics an intravenous solution consisting of glucose-insulin-potassium (GIK) had no reduction in the rate of progression to heart attack and no improvement in 30-day survival, although GIK was associated with a lower rate of the composite outcome of cardiac arrest or in-hospital death, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.
Laboratory studies suggest that ...
DNA traces cattle back to a small herd domesticated around 10,500 years ago
2012-03-27
All cattle are descended from as few as 80 animals that were domesticated from wild ox in the Near East some 10,500 years ago, according to a new genetic study.
An international team of scientists from the CNRS and National Museum of Natural History in France, the University of Mainz in Germany, and UCL in the UK were able to conduct the study by first extracting DNA from the bones of domestic cattle excavated in Iranian archaeological sites. These sites date to not long after the invention of farming and are in the region where cattle were first domesticated.
The ...
Researchers find diets high in saturated fat not associated with adverse effects in healthy cats
2012-03-27
A collaborative team of researchers has found that cats are able to consume a diet relatively high in fat without raising cholesterol levels. The research also showed that, as long as cats' daily calorie intake remains constant, increasing the proportion of fat in the diet will not affect the likelihood of weight gain. The findings advance understanding of how cats handle dietary fat and reinforce the differences between the nutritional needs of cats and humans.
This research was conducted by scientists from the University of Glasgow and the WALTHAM® Centre for Pet Nutrition ...
Signs of thawing permafrost revealed from space
2012-03-27
Permafrost is ground that remains at or below 0°C for at least two consecutive years and usually appears in areas at high latitudes such as Alaska, Siberia and Northern Scandinavia, or at high altitudes like the Andes, Himalayas and the Alps.
About half of the world's underground organic carbon is found in northern permafrost regions. This is more than double the amount of carbon in the atmosphere in the form of the greenhouse gases carbon dioxide and methane.
The effects of climate change are most severe and rapid in the Arctic, causing the permafrost to thaw. When ...
Young infants' imitation not guided by rational thinking
2012-03-27
This press release is available in German.
In a widely noticed study, developmental psychologists reported that 14-month-old infants imitate an unusual action if it was chosen deliberately by the person they observed, but not if it could be attributed to external constraints. This selective imitation was put forth as evidence for an early understanding of rational action and action goals. Scientists at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig now present a much simpler explanation for the finding. A replication study revealed that ...
9 million bicycles, but what about the cars in Beijing?
2012-03-27
Forget the fact of there being "9 million bicycles in Beijing, that's not a fact. Indeed, motor vehicle traffic is fast becoming a big problem that has led to unsustainable pollution and draconian rules in some parts of the city. Now, Nan Ji of the Hebei United University in China and colleagues have developed an algorithm to help traffic planners optimize the flow of traffic across roundabouts.
Writing in the International Journal of Innovative Computing and Applications, Ji and colleagues at the Tangshan Tanggang Expressway Management Office and Tian Jin Polytechnic ...
Rio+20 must radically rethink innovation
2012-03-27
A radical new approach to innovation is urgently needed to ensure a fair and green economy and avoid reversing progress made on global poverty reduction, according to leading scientists.
Ahead of the United Nations Conference on Sustainable Development, or Rio+20, the ESRC STEPS Centre calls on negotiators to rethink the way science and innovation can contribute to the Sustainable Development Goals (SDGs) that are likely to emerge from Rio.
Rio+20 is a golden opportunity to enhance the role that science, technology and innovation of many kinds can play in building ...